It was reported that several weeks after implant the patient developed an infection.The implantable cardioverter defibrillator (icd) and leads were explanted.The patient is enrolled in the adapt response clinical study.No further patient complications have been reported as a result of this event.(b)(6) 2015: additional information was received regarding this event.It was further reported that the patient awoke with fever, diaphoresis, and malaise.Patient was sent to emergency room (er) and found to have a pericardial effusion and was tachycardic.A chest tube was placed and drained a thick reddish exudate which was found to contain gram positive cocci.Patient was placed on intravenous antibiotics and underwent exploration of his thoracotomy incision and pacemaker pocket.This revealed infection in both locations.The device and epicardial leads were removed.Echocardiography showed resolved pericardial effusion but a large vegetation traversing the tricuspid valve and possibly adherent to one of the remaining endovascular leads.The patient underwent cardiopulmonary bypass, removal of the vegetative masses and endovascular leads, and open debridement of the infected areas.The patient was discharged home on iv antibiotics and the system was replaced on the right side approximately three months later.
|
Concomitant medical products: product id 6996sq58, serial# (b)(4), implanted: (b)(6) 2014, explanted: (b)(6) 2014, product id 4968-60, serial# (b)(4), implanted: (b)(6) 2014, explanted: (b)(6) 2014, product id 6935m62, serial# (b)(4), implanted: (b)(6) 2014, explanted: (b)(6) 2014.(b)(4).(b)(6).
|